Digital Look

Welcome to Digital Look++,
you are not logged in

Merck & Co. Inc. (MRK)

101.40

Merck increases antibiotic offering with $9.5bn ...	09-Dec-2014	Telegraph
Reckitt Benckiser bows out of race for Merck's c...	01-May-2014	Telegraph
Patents Ending, Eli Lilly Chases New Drugs	01-Oct-2010	New York Times
Another Loss for Pfizer in Drug Suits	25-Nov-2009	New York Times
Bristol-Myers, partner AstraZeneca get EU approv...	06-Oct-2009	Chicago Tribune
Abbott buys Belgian drug unit for $6.6B	29-Sep-2009	Wall Street Journal
Abbott in $6.6 Billion Deal for Drug Unit	29-Sep-2009	New York Times
Jury Deadlock Ends a Trial Over Merck’s Bone Drug	13-Sep-2009	New York Times
Merck & Co. shareholders OK $41.1 billion acquis...	08-Aug-2009	Chicago Tribune
Schering and Merck Are Settling Vytorin Suits	06-Aug-2009	New York Times
Merck, insurance plans settle Vioxx suits for $80M	04-Aug-2009	USA Today
Merck Selling Stake in Animal Venture	31-Jul-2009	New York Times
Sanofi and Merck Announce $4 Billion Merial Sale	31-Jul-2009	New York Times
Wyeth shareholders OK Pfizer buying company	21-Jul-2009	Wall Street Journal
AstraZeneca, Merck team up on cancer treatment	02-Jun-2009	LA Times
Pfizer Profit Dips on Ease in Demand for Lipitor	29-Apr-2009	New York Times
Merck Quarterly Profit Plunges 57%	21-Apr-2009	New York Times
Glaxo to Acquire Lab for $2.9 Billion	20-Apr-2009	New York Times
Glaxo and Pfizer Join Forces to Develop and Mark...	17-Apr-2009	New York Times
Biotech deals involve 3 firms in Bay Area	13-Mar-2009	LA Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Time	Volume / Share Price
	0 @ 0.00